Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dominari Holdings Inc.SPEX · Entity 7162 | Director | February 16, 2018 | February 21, 2018 |
| Silo Pharma, Inc.SILO · Entity 8320 | Director · Chief Executive Officer | December 15, 2025 | December 16, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dominari Holdings Inc.
Report date February 16, 2018 · Filed February 21, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.0001 par value per shareSEC Table I · non-derivative | Direct | 20,000 |
Reported balance
After 2018-02-16 transaction · row 1
1 source rowRow 1 · 2018-02-16 · Grant · Acquired 20,000 · Balance 20,000 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.50 · Expires 2028-02-15 | Direct | 50,000 |
Reported balance
After 2018-02-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-02-16 · Grant · Acquired 50,000 · Balance 50,000 F1: 50% of the options vest on February 16, 2018 and the remaining 50% shall vest on August 16, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: 50% of the options vest on February 16, 2018 and the remaining 50% shall vest on August 16, 2018.
Silo Pharma, Inc.
Report date December 15, 2025 · Filed December 16, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 216,932 |
Ending reported balance
After 2025-12-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-12-15 · Purchase · Acquired 2,500 · Balance 214,432 Row 2 · 2025-12-15 · Purchase · Acquired 2,500 · Balance 216,932 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2018 Filed Feb 21, 2018 00:44 UTC | Dominari Holdings Inc. SPEX · Entity 7162 | GrantCommon Stock, $.0001 par value per share | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-001339 · s109123_form4.xml · nonDerivative · entry 1 Weisblum Eric · CIK 0001569077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| May 31, 2017 Filed Jun 7, 2017 22:42 UTC | Dominari Holdings Inc. SPEX · Entity 7162 | GrantStock Option (right to buy) · Derivative | 3,947 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001615774-17-003038 · s106491_form4.xml · derivative · entry 1 Weisblum Eric · CIK 0001569077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,948 Underlying: Common Stock · 3,947 shares Expires 2027-05-30 F1 · derivative.exercise_date: 50% of the options vest on May 31, 2017, and the remaining 50% shall vest on May 31, 2018. Read SEC document |
| August 24, 2016 Filed Nov 22, 2016 21:30 UTC | Dominari Holdings Inc. SPEX · Entity 7162 | GrantStock Option (right to buy) · Derivative | 3,947 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001615774-16-008540 · s104779_form4.xml · derivative · entry 1 Weisblum Eric · CIK 0001569077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,947 Underlying: Common Stock · 3,947 shares Expires 2026-08-23 F1 · derivative.exercise_date: 50% of the options vest on August 24, 2016, and the remaining 50% shall vest on August 24, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.